 | Webcast Q1 2012 Covidien plc Earnings Conference Call (Live) 01/26/12 at 8:30 a.m. ET |
| |||||||||
 |
|
| Recent News | More >> |
| Covidien Reports First-Quarter Results - 01/26/12 |
| View PDF Net sales up 5%; Medical Devices sales up 6% First-quarter diluted GAAP earnings per share from continuing operations were $1.02; excluding specified items, adjusted diluted earnings per share from continuing operations were $1.13... More >> |
|
| Clinical Data for DURABILITY II Study Presented at ISET 2012 - 01/24/12 |
| MIAMI--(BUSINESS WIRE)--Jan. 24, 2012-- Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that one-year results on the use of its EverFlex™ stent for superficial femoral artery stenting w... More >> |
|
| Covidien Appoints New Leader for Vascular Therapies Business - 01/23/12 |
| MANSFIELD, Mass.--(BUSINESS WIRE)--Jan. 23, 2012-- Covidien (NYSE: COV), a leading global supplier of healthcare products, today announced that Stacy Enxing Seng has been appointed President of the Company’s Vascular Therapie... More >> |
|
| Covidien Releases Clinical Data on Plaque Excision for the Treatment of Calcified Lesions - 01/23/12 |
| Final Results from DEFINITIVE Ca++ Clinical Study Presented at ISET 2012 MIAMI--(BUSINESS WIRE)--Jan. 23, 2012-- Covidien (NYSE:COV), a leading global provider of healthcare products, today released the results... More >> |
|
| Covidien CEO Elected Chairman of the Board - 01/20/12 |
| CEO and President José E. Almeida Assumes Additional Duties DUBLIN--(BUSINESS WIRE)--Jan. 20, 2012-- Covidien plc (NYSE: COV) today announced that its Board of Directors has elected President and Chief Executiv... More >> |
|
| Covidien Provides Update on Voluntary Recall of BIS™ Bilateral Sensors - 01/19/12 |
| BOULDER, Colo.--(BUSINESS WIRE)--Jan. 19, 2012-- On November 8, 2011, Covidien initiated a voluntary recall of certain lots of its BIS™ Bilateral Sensors, due to a modification which inadvertently reversed the reference and l... More >> |
|
| Covidien Declares Quarterly Cash Dividend - 01/19/12 |
| DUBLIN--(BUSINESS WIRE)--Jan. 19, 2012-- Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.225 per ordinary share. The dividend is payable on February 22, 2012, ... More >> |
|
| Covidien Contraindicates the Use of Duet TRSTM for Thoracic Surgery, Implements a Voluntary Recall - 01/16/12 |
| MANSFIELD, Mass.--(BUSINESS WIRE)--Jan. 16, 2012-- Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it is conducting a voluntary recall of all production lots for the Duet TRSTM Uni... More >> |
|
| Covidien Appoints Mark Trudeau President of Pharmaceuticals Segment - 01/12/12 |
| DUBLIN--(BUSINESS WIRE)--Jan. 12, 2012-- Covidien plc (NYSE:COV), a leading global provider of healthcare products, today announced the appointment of Mark Trudeau as president of its Pharmaceuticals segment and a senior vice... More >> |
|
| Covidien Donates Additional $1 Million to Support Haitian Hospital - 01/11/12 |
| Company’s Contributions to Partners In Health for Haiti Now Total $3.5 Million MANSFIELD, Mass.--(BUSINESS WIRE)--Jan. 11, 2012-- Covidien (NYSE: COV), a leading global provider of healthcare products, today an... More >> |
|
|
| Upcoming Events | More >> |
| ||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
